Phase I trial of the combination of flavopiridol and imatinib mesylate in patients with Bcr-Abl+ hematological malignancies.
about
Cyclin-dependent kinase inhibitor therapy for hematologic malignanciesInhibition of STAT5: a therapeutic option in BCR-ABL1-driven leukemiaRepurposing Kinase Inhibitors as Antiviral Agents to Control Influenza A Virus Replication.SNS-032 inhibits mTORC1/mTORC2 activity in acute myeloid leukemia cells and has synergistic activity with perifosine against Akt.Candidate cancer-targeting agents identified by expression-profiling arrays.Comparative drug screening in NUT midline carcinoma.Recent agents targeting HIF-1α for cancer therapy.Evidence-based guidelines for the use of tyrosine kinase inhibitors in adults with Philadelphia chromosome-positive or BCR-ABL-positive acute lymphoblastic leukemia: a Canadian consensus.Highlights of the Latest Advances in Research on CDK Inhibitors.Overview of CDK9 as a target in cancer research.
P2860
Q24561485-D3ED1104-7401-40CE-823F-C77C76BFF1CEQ27004027-301D94E1-1BEA-47B3-97E3-28E9CB3E1EBCQ35698322-3C31E5BF-CD61-454A-8493-FDC179086D33Q36688940-9B416443-5E7C-40B0-93C6-E4BC50EC772DQ36802115-D13F4CD8-7E92-42F0-A758-3D306F57F1B0Q37632187-ECA7803C-5C80-425C-9779-A5A3EE63C89BQ38042021-250A6E3E-540A-4585-99BD-6A5675499CB2Q38207017-8B8A44AB-D143-47B4-9D68-5718AED41DF4Q38263222-C846F8EB-338E-48F3-AB78-682D3CA99EC0Q38696353-6E95A817-1B6E-4BC4-9EA7-BC60975A0C29
P2860
Phase I trial of the combination of flavopiridol and imatinib mesylate in patients with Bcr-Abl+ hematological malignancies.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Phase I trial of the combinati ...... l+ hematological malignancies.
@ast
Phase I trial of the combinati ...... l+ hematological malignancies.
@en
type
label
Phase I trial of the combinati ...... l+ hematological malignancies.
@ast
Phase I trial of the combinati ...... l+ hematological malignancies.
@en
prefLabel
Phase I trial of the combinati ...... l+ hematological malignancies.
@ast
Phase I trial of the combinati ...... l+ hematological malignancies.
@en
P2093
P2860
P1476
Phase I trial of the combinati ...... bl+ hematological malignancies
@en
P2093
A Dimitrios Colevas
Brenda W Cooper
Chiyo K Imamura
Connie Honeycut
Edward B Perkins
Emmanouil Kontopodis
John D Roberts
Judith E Karp
Martha D Wellons
Merrill J Egorin
P2860
P2888
P304
P356
10.1007/S00280-012-1839-5
P577
2012-02-15T00:00:00Z